Adverum Biotechnologies Inc (ADVM)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| CEO: | Laurent Fischer |
| Employees: | 190 |
| Web site: | adverum.com |
|
100 CARDINAL WAY, REDWOOD CITY, CA, 94063
(650) 649-1004
| |
-
Formally known as:
- AVALANCHE BIOTEC
| Date | Ratio |
|---|---|
| 2024-03-21 | 1:10 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Adverum Biotechnologies, Inc. develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate. The company was incorporated in 2006 and is headquartered in Redwood City, California.
Please log in first to see chart